Intersection between patients with CKD and patients with CVD shows that approximately half of patients with CKD have CAD,
whereas 20% of those with CAD will meet a definition of CKD. Those with combined CKD and CAD have been shown to have
the benefits of RAAS blockade, as shown. RAAS indicates renin-angiotensin-aldosterone system; CKD, chronic kidney disease;
CAD, coronary artery disease; ESRD, end-stage renal disease.
Per cercare un linguaggio comune cardionefrologico, un panel di esperti in nefrologia, cardiologia, ma anche in terapia intensiva e cardiochirurgia ha redatto recentemente un documento sulle sindromi cardio-renali.
(A) The incidence of ACM according to eGFR; the participants were categorized according to eGFR: Group 1, ≥105 mL/min/1.73m2; Group 2, 90–104 mL/min/1.73m2; Group 3, 75–89 mL/min/1.73m2; Group 4, 60–74 mL/min/1.73m2; Group 5, <60 mL/min/1.73m2. (B) The incidence of ACM according to the proteinuria level; proteinuria (trace or more) was analyzed by urine dipstick.